Suppr超能文献

揭示可用药基因组的曙光。

Glimmers in illuminating the druggable genome.

机构信息

Office of the Director, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

Office of the Director, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland 20817, USA.

出版信息

Nat Rev Drug Discov. 2018 May;17(5):301-302. doi: 10.1038/nrd.2017.252. Epub 2018 Jan 19.

Abstract

Much biomedical research continues to focus on a small proportion of the human genome that has already been studied intensively. The Illuminating the Druggable Genome programme, initiated as a pilot project by the US National Institutes of Health Common Fund in 2014, is now being implemented to accelerate the investigation of subsets of understudied proteins that have potential therapeutic relevance.

摘要

许多生物医学研究仍然集中在已经被深入研究过的一小部分人类基因组上。Illuminating the Druggable Genome 计划于 2014 年由美国国立卫生研究院共同基金作为试点项目发起,目前正在实施,以加速对具有潜在治疗相关性的研究较少的蛋白质亚类的研究。

相似文献

1
Glimmers in illuminating the druggable genome.揭示可用药基因组的曙光。
Nat Rev Drug Discov. 2018 May;17(5):301-302. doi: 10.1038/nrd.2017.252. Epub 2018 Jan 19.
3
Open to interpretation.有待解读。
Nat Biotechnol. 2013 Aug;31(8):661. doi: 10.1038/nbt.2665.
4
Support for the Human Cancer Genome Project.对人类癌症基因组计划的支持。
Science. 2005 Dec 9;310(5754):1615. doi: 10.1126/science.310.5754.1615b.
5
Genomics. Tackling the cancer genome.基因组学。攻克癌症基因组。
Science. 2005 Jul 29;309(5735):693. doi: 10.1126/science.309.5735.693.
6
The ENCODE (ENCyclopedia Of DNA Elements) Project.DNA 元件百科全书(ENCODE)计划
Science. 2004 Oct 22;306(5696):636-40. doi: 10.1126/science.1105136.
8
Q&A: Stephen J. O'Brien.问答:斯蒂芬·J·奥布赖恩。
Curr Biol. 2007 Mar 6;17(5):R152-4. doi: 10.1016/j.cub.2006.12.006.
9
Genomics moves into the clinic.基因组学走进临床。
Biotechniques. 2012 Feb;52(2):73-6. doi: 10.2144/000113806.

引用本文的文献

8
Role of silent mutations in KRAS -mutant tumors.沉默突变在KRAS突变型肿瘤中的作用。
Chin Med J (Engl). 2025 Feb 5;138(3):278-288. doi: 10.1097/CM9.0000000000003405. Epub 2024 Dec 10.
10
off-target profiling for enhanced drug safety assessment.用于增强药物安全性评估的脱靶分析
Acta Pharm Sin B. 2024 Jul;14(7):2927-2941. doi: 10.1016/j.apsb.2024.03.002. Epub 2024 Mar 6.

本文引用的文献

1
A comprehensive map of molecular drug targets.分子药物靶点综合图谱。
Nat Rev Drug Discov. 2017 Jan;16(1):19-34. doi: 10.1038/nrd.2016.230. Epub 2016 Dec 2.
5
Too many roads not taken.太多未选择的道路。
Nature. 2011 Feb 10;470(7333):163-5. doi: 10.1038/470163a.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验